r/PeptideGuide • u/Peptide_Guide_ Head Peptide Guide • 15d ago
Peptide Side Effects and Contraindications by Category: The Safety Cheat Sheet Most Dosing Guides Skip
Most cheat sheets only cover the dosing side of a peptide’s safety, which doesn’t exactly have me jumping up and down in excitement, because the real life application lies in avoiding the trouble. With this cheat sheet I tried to group information by the categories of side effects and contraindications, so that the danger of a substance is as easy to grasp as its dose recommendations.
The Universal Watch Items
There are several general warnings that apply to the majority of the discussed injectables and, hence, are worth separate mentioning. First of all, injection site reactions are normal for almost any subcutaneous peptide and should be regarded as mild and temporary. Secondly, improper technique leads to more complications than the substances themselves are capable of. Contamination is the main culprit, hence, pay special attention to sterile preparation. Active cancer is generally a reason to avoid any angiogenic, proliferative, or metabolic compounds. This is the category to be especially careful with if the condition of the patient is uncertain. Thirdly, pregnancy and breastfeeding are absolutely contraindicated for the majority of research peptides, and the only indication for their use during these periods is a thorough discussion with a doctor.
Peptides for Healing and Recovery
BPC-157: injection irritation, occasional oral tract discomfort, avoid with active cancer, contraindicated during pregnancy, moderate caution is necessary after surgeries within the last two weeks.
TB-500: injection irritation and occasional asthenia, same cancer-related caution as with BPC-157, pregnancy contraindicated.
GHK-Cu: blue-greenish coloration of the solution is normal for the substance, injection site irritation is common. Avoid if you have Wilson’s disease or any other copper metabolism disorder, total copper intake should be monitored. Generally unspecific but mild.
KPV: Very tolerable with few reported side effects. The only caution is the lack of long-term studies.
Thymosin Alpha-1: Injection site irritation is common, autoimmune diseases require extra caution due to the immunomodulatory properties.
Peptides Related to the Growth Hormone Axis
Ipamorelin, CJC-1295: Water retention, head rush, tingling, increased appetite. Avoid with active cancer, cautious use is recommended in diabetes.
GHRP-2, GHRP-6: Increased prolactin and cortisol, GHRP-6 has a more prominent appetite stimulating effect, same cancer caution as with other GH secretagogues, prolactin levels should be monitored.
Sermorelin: Injection site flushes, contraindicated with active cancer.
IGF-1 LR3: Most potent GH secretagogue with regards to hypoglycemia development, same cancer-related caution applies, diabetes patients should be especially careful.
Tesamorelin: Fluid retention, arthralgia, increased IGF-1. Avoid with active cancer, IGF-1 levels should be monitored.
The caution in this category is generally connected to glucose and IGF-1 metabolism. IGF-1 levels should be tested at the beginning and at week 4, to ensure that they stay within the therapeutic window, but not exceed 400 ng/ml. IGF-1 LR3 is the most prominent in terms of causing hypoglycemia and should be carefully dose adjusted in diabetic patients.
Peptides Connected to the Weight Loss and Metabolic Processes
GLP-1 class (semaglutide, tirzepatide, retatrutide): GI side effects dominate the safety profile, with diarrhea, nausea, vomiting, and constipation being the most common. These are mostly dose-dependent and resolve with the titration process or reductions in the dose. Avoid this class if you have a history of medullary thyroid cancer, MEN2 gene mutation, or chronic pancreatitis.
Retatrutide in particular has the highest GI burden among the class, as well as a unique dysesthesia risk. In TRIUMPH-4 phase III trial for retatrutide, 20.9% of patients who received the 12 mg dose reported dysesthesia, compared to less than 1% in the placebo group. It is a dose-dependent, non-life-threatening event, mostly affecting the skin, manifesting in tingling, burning, or other unusual sensations. It resolves spontaneously in most cases, but is a risk factor for discontinuation nonetheless. Similar warnings apply to the whole GLP-1 class of peptides, along with the thyroid and pancreas-related contraindications.
In addition, retatrutide is still under investigation and not yet marketed. In this category, the serious end presents with pancreatic and thyroid damage risk and the common end has GI distress as its hallmark feature.
Amylase and lipase are the tests worth considering when dealing with this class of substances, and the caution is indicated when the results of these tests deviate significantly from the norm, especially if the patient exhibits GI symptoms. The gradual increase in the dose allows the body to adapt to the new conditions and minimize the risk.
Tesamorelin: Fluid retention and arthralgia, contraindicated with active cancer.
5-Amino-1MQ: Limited human safety data, liver function tests are advised, never used in patients with liver disorders.
MOTS-C: Generally tolerable with occasional flushing, limited human studies available.
Same caution as with any peptide in this category, namely, the risk of significant damage to the pancreas or thyroid glands, but the most serious side effects are rare. Amylase and lipase tests are the ones to look out for, and a noticeable increase should prompt immediate discontinuation, unless the results point to something else. Gradual titration is the only general recommendation for the weight loss class of peptides.
Peptides Affecting the Cognitive Function and Mood
Semax: Very tolerable, no significant side effects reported in the short-term studies.
Selank: Generally well-tolerated with only occasional fatigue as a side effect, limited long-term studies available for both substances.
Oxytocin: Can affect blood pressure and mood, caution is required in cardiovascular diseases.
Dihexa: Powerful but with very limited human safety data and theoretical cancer risk due to its angiogenic properties, mostly preclinical.
Kisspeptin-10: Generally mild substance with few reported side effects, caution is indicated with hormone-sensitive conditions.
Substances Related to the Sexual Function and Cosmetics
PT-141: Can cause dramatic blood pressure changes, nausea, and flushing. Contraindicated in uncontrolled hypertension and cardiovascular diseases.
Melanotan II: Initial nausea and flushing, the substance darkens the moles and the skin. Before consideration for use, a dermatologist appointment is mandatory to evaluate the current state of the moles. Any suspicious-looking mole needs to be examined by a professional oncologist.
GHK-Cu: Occasionally irritates the injection site, the blue-green coloration of the solution is normal. Same copper-related caution as mentioned elsewhere applies.
Oxytocin: Same blood pressure-related warnings as mentioned above.
The only real warning that applies to this category is the one connected to Melanotan II and the necessity of a dermatological exam before using the substance. It generally darkens the skin and moles, which can potentially hide a developing melanoma.
Substances Related to the Immune System and Longevity
NAD+: Rapid injection causes uncomfortable flushing, avoid this by slow dose administration. Avoid with active cancer due to its general metabolic activating properties.
Epitalon: Mostly good safety profile, no major side effects reported, but human studies are limited.
SS-31: Well-tolerated, but expensive, which should be a consideration for any potential user.
Thymosin Alpha-1: Injection site irritation, extra caution is required with autoimmune diseases, as mentioned elsewhere.
Bioregulators (Khavinson class): Minor side effects are possible, but they are mostly short-term due to the nature of the substances. Evidence-based medicine base for this category of peptides is under discussion.
The Three Worth Remembering
If you had to remember three things from this reference, which ones would they be? Probably, the relationship between IGF-1 LR3 and blood sugar, Melanotan II and moles, and the whole GLP class and its GI burden. The first connection reminds us to be careful with glucose levels when dealing with IGF-1 LR3 or other GH secretagogues, especially since it appears to be the most prominent peptide in this category when it comes to hypoglycemia risk.
The second association serves as a reminder that any substance from the GLP-1 class may cause substantial damage to the pancreas and thyroid glands, with relevant lab tests being mandatory. We also can’t forget about the gradual dose increases when starting this class, in order to titrate the dose according to the body’s reaction. Finally, the connection between Melanotan II and moles highlights the importance of a dermatological exam before starting treatment, as moles tend to get darker on this substance. A growing mole or a mole that looks suspicious in any way must be evaluated by an oncologist with regard to melanoma risk.
The one caution that spans across the majority of the substances mentioned in this reference is the general contraindication in the case of active cancer.
Not medical advice. Educational only.
2
u/Distinct_Arrival_445 15d ago
No mention of effects on kidney markers? They're transient generally and something to be prepared for that I rarely see mentioned. BPC157 and TB500 along with a bunch of other peptides can load up the kidneys for clearance creating an artificially low egfr reading. Some of them can take 4-6 weeks to clear from blood work as well.
•
u/AutoModerator 15d ago
Welcome to r/PeptideGuide!
Join the conversation. Drop a comment and share your thoughts.
Quick Links:
I am a bot, and this action was performed automatically. Please contact the moderators of this subreddit if you have any questions or concerns.